human growth hormone

Somatotropin (6-13) is a growth hormone.

Growth Hormone Releasing Factor human TFA 是下丘脑多肽，通过与GHRHR结合，刺激生长激素生成和释放。

Human growth hormone-releasing factor stimulates GH production and release by binding to the GHRH Receptor (GHRHR) on cells in the anterior pituitary.Growth hormone-releasing hormone is a hormone produced in the hypothalamus. The main role of growth hormo

Human growth hormone-releasing factor acetate 是一种下丘脑多肽，通过与垂体前叶细胞上的 GHRH 受体 (GHRHR) 结合来刺激 GH 的产生和释放。

TM-N1324 是一种 GPR39 激动剂。 TM-N1324 在没有和存在 Zn2+ 的情况下分别以 280 nM 和 9 nM 的高效率和效力激活人 GPR39。 TM-N1324 对鼠 GPR39 表现出相似的效力，EC50 分别为 180 nM 和 5 nM。

FSH receptor antagonist 1 (compound 10) 是一种高效的G(s)蛋白偶联人类促卵泡激素 (FSH) 受体拮抗剂，在表达人类FSH受体的细胞系中的IC50值为28 nM。该化合物在体外小鼠模型中显著抑制卵泡生长和排卵。

Gitogenin 是一种从Tribulus longipetalus 整株中分离出来的天然类固醇，是一种 UDP-葡萄糖醛酸转移酶 1A4 (UGT1A4) 和 α-葡萄糖苷酶的选择性抑制剂，其IC50分别为 0.69 µM (使用三氟拉嗪为底物) 和 37.2 μM，对人类主要细胞色素 P450 亚型的活性无抑制作用。

TTA-P1 is a highly potent compound that effectively inhibits human T-type calcium channels, which are involved in various physiological processes such as neuronal burst firing, hormone secretion, and cell growth. With its unique state-independent properties, TTA-P1 holds promising potential for advancing research on absence epilepsy [1].

IRC-083927 HCl is novel and potent microtubule inhibitor with potential anticancer activity. IRC-083927 inhibits the tubulin polymerization by a binding to the colchicine site. IRC-083927 inhibits in vitro cell growth of human cancer cell lines in the low nanomolar range. More interesting, it remains highly active against cell lines resistant to microtubule-interacting agents (taxanes, Vinca alkaloids, or epothilones). Chronic oral treatment with IRC-083927 (5 mg kg) inhibits the growth of two human tumor xenografts in nude mice (C33-A, human cervical cancer and MDA-MB-231, human hormone-independent breast cancer). Together, the antitumor effects induced by IRC-083927 on tumor models resistant to tubulin agents support further investigations to fully evaluate its potential for the treatment of advanced cancers, particularly those resistant to current clinically available drugs.

Mecasermin（Human IGF-I; FK 780），一种重组人胰岛素样生长因子I（IGF-I），主要用于研究因生长激素（GH）受体缺陷或GH抑制抗体导致的GH不敏感性而引起的生长障碍。

[His1,Nle27] GHRF (1-32), amide, human为一种生长激素释放激素（GHRH）类似物，对GHRHR受体具有较好的亲和力。

pTH (1-37) (human) 为甲状旁腺激素（PTH）的一段，能诱导cAMP产生并提升碱性磷酸酶活性，进而增强尿毒症动物的生长速度、骨钙含量及骨矿物质密度（BMD），显示出对骨质疏松症研究的应用潜力。

Acetyl-(D-Arg2)-GRF (1-29) amide (human) 是一种针对人体的生长激素释放因子(GRF)拮抗剂，其主要作用是抑制生长激素(GH)的释放，广泛应用于内分泌学领域的研究。

AOD9604 acetate(221231-10-3 free base) 是一种基于人类生长激素的潜在抗肥胖肽。

LEAP-2 (Human liver expressed antimicrobial peptide-2) 是一种抗菌肽，是生长素释放肽的内源性竞争性拮抗剂，也是组成型 GHS-R1a 活性的反向激动剂，可用于研究肥胖和其他代谢疾病。

'(D-Ala2)-GRF (1-29) amide (human)' 为一种GRF的超激动剂，其GH释放活性在猪和大鼠体内极为显著，大约为GRF (1-29)活性的50倍。

S1H是一种人造肽类模拟物，模仿人类生长激素的第36至51个氨基酸，且为生长激素受体的拮抗剂。在溶液中呈现α-螺旋结构，并在100和200纳摩尔（nM）的浓度下，能降低SK-MEL-28和MALME-3M黑色素瘤细胞系以及IM-9 B细胞淋巴细胞中，由人类生长激素及泌乳素诱导的STAT5磷酸化。

GLP-2(1-33) (human) is an enteroendocrine hormone that stimulates intestinal epithelium growth.

Somatostatin, also known as growth hormone-inhibiting hormone, is a naturally-occurring peptide hormone of 14 or 28 amino acid residues that regulates the endocrine system. It is secreted by the D cells of the islets to inhibit the release of insulin and